Apyx Medical Corporation (APYX)
Apyx Medical Statistics
Share Statistics
Apyx Medical has 37.79M shares outstanding. The number of shares has increased by 9.09% in one year.
| Shares Outstanding | 37.79M |
| Shares Change (YoY) | 9.09% |
| Shares Change (QoQ) | 0.4% |
| Owned by Institutions (%) | 45.93% |
| Shares Floating | 32.17M |
| Failed to Deliver (FTD) Shares | 13 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 139K, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 139K |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.43% |
| Short Ratio (days to cover) | 5.34 |
Valuation Ratios
The PE ratio is -2.39 and the forward PE ratio is -2.61. Apyx Medical's PEG ratio is -0.11.
| PE Ratio | -2.39 |
| Forward PE | -2.61 |
| PS Ratio | 1.17 |
| Forward PS | 0.5 |
| PB Ratio | 3.95 |
| P/FCF Ratio | -2.99 |
| PEG Ratio | -0.11 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Apyx Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.26, with a Debt / Equity ratio of 0.34.
| Current Ratio | 5.26 |
| Quick Ratio | 4.56 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | -0.29 |
| Debt / FCF | -0.26 |
| Interest Coverage | -3.19 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $218.65K |
| Profits Per Employee | $-106.65K |
| Employee Count | 220 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 2.48 |
Taxes
| Income Tax | 252K |
| Effective Tax Rate | -1.08% |
Stock Price Statistics
The stock price has increased by -25.18% in the last 52 weeks. The beta is 0.92, so Apyx Medical's price volatility has been higher than the market average.
| Beta | 0.92 |
| 52-Week Price Change | -25.18% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 46.09 |
| Average Volume (20 Days) | 41K |
Income Statement
In the last 12 months, Apyx Medical had revenue of 48.1M and earned -23.46M in profits. Earnings per share was -0.66.
| Revenue | 48.1M |
| Gross Profit | 29.36M |
| Operating Income | -18.84M |
| Net Income | -23.46M |
| EBITDA | -16.8M |
| EBIT | -17.4M |
| Earnings Per Share (EPS) | -0.66 |
Balance Sheet
The company has 31.74M in cash and 4.87M in debt, giving a net cash position of 26.87M.
| Cash & Cash Equivalents | 31.74M |
| Total Debt | 4.87M |
| Net Cash | 26.87M |
| Retained Earnings | -77.91M |
| Total Assets | 64.84M |
| Working Capital | 45.72M |
Cash Flow
In the last 12 months, operating cash flow was -18.05M and capital expenditures -722K, giving a free cash flow of -18.77M.
| Operating Cash Flow | -18.05M |
| Capital Expenditures | -722K |
| Free Cash Flow | -18.77M |
| FCF Per Share | -0.53 |
Margins
Gross margin is 61.04%, with operating and profit margins of -39.18% and -48.78%.
| Gross Margin | 61.04% |
| Operating Margin | -39.18% |
| Pretax Margin | -48.45% |
| Profit Margin | -48.78% |
| EBITDA Margin | -34.93% |
| EBIT Margin | -39.18% |
| FCF Margin | -39.02% |
Dividends & Yields
APYX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for APYX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -0.51 |
| Piotroski F-Score | 2 |